DK115990B - Fremgangsmåde til fremstilling af 4,17β-dihydroxy- eller 4-acyloxy-17β-hydroxy-17α-methyl-3-oxo-1,4-androstadien- eller -1,4,6-androstatrien-forbindelser.
- Google Patents
Fremgangsmåde til fremstilling af 4,17β-dihydroxy- eller 4-acyloxy-17β-hydroxy-17α-methyl-3-oxo-1,4-androstadien- eller -1,4,6-androstatrien-forbindelser.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici ItaliafiledCriticalFarmaceutici Italia
Publication of DK115990BpublicationCriticalpatent/DK115990B/da
C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07J—STEROIDS
C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07J—STEROIDS
C07J75/00—Processes for the preparation of steroids in general
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
Steroid Compounds
(AREA)
DK2061AA1960-01-041961-01-03Fremgangsmåde til fremstilling af 4,17β-dihydroxy- eller 4-acyloxy-17β-hydroxy-17α-methyl-3-oxo-1,4-androstadien- eller -1,4,6-androstatrien-forbindelser.
DK115990B
(da)
Fremgangsmåde til fremstilling af 4,17β-dihydroxy- eller 4-acyloxy-17β-hydroxy-17α-methyl-3-oxo-1,4-androstadien- eller -1,4,6-androstatrien-forbindelser.
Fremgangsmåde til fremstilling af 4,17β-dihydroxy- eller 4-acyloxy-17β-hydroxy-17α-methyl-3-oxo-1,4-androstadien- eller -1,4,6-androstatrien-forbindelser.
Fremgangsmåde til fremstilling af 4,17β-dihydroxy- eller 4-acyloxy-17β-hydroxy-17α-methyl-3-oxo-1,4-androstadien- eller 1,4,6-androstatrienforbindelser.